We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+11.48%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$115M
AUM Growth
+$71M
Cap. Flow
+$64.8M
Cap. Flow %
56.57%
Top 10 Hldgs %
97.7%
Holding
24
New
9
Increased
4
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$2.64M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.78M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.04M
4
EHTH icon
eHealth
EHTH
+$924K
5
TBT icon
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
+$293K

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$209K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$208K
3
META icon
Meta Platforms (Facebook)
META
+$156K
4
RCM
R1 RCM Inc. Common Stock
RCM
+$137K
5
V icon
Visa
V
+$68.8K

Sector Composition

Rank Sector Weight
1 Healthcare 25.06%
2 Industrials 12.96%
3 Communication Services 4.86%
4 Financials 1.98%
5 Technology 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$466B
$51.3M 44.83%
+160,000
New +$47.2M
RCM
2
DELISTED
R1 RCM Inc. Common Stock
RCM
$14.8M 12.96%
990,000
-10,000
-1% -$137K
APO icon
3
CALL
Apollo Global Management
APO
$69.5B
$10.4M 9.1%
+165,000
New +$11M
CVS icon
4
CVS Health
CVS
$137B
$9.68M 8.45%
130,280
+31,483
+32% +$2.64M
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.99M 7.85%
92,500
+10,000
+12% +$1.04M
ZBH icon
6
Zimmer Biomet
ZBH
$17.6B
$8.08M 7.05%
62,529
-1
-0% -$126
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.22T
$4.78M 4.18%
46,000
– –
EHTH icon
8
eHealth
EHTH
$47.3M
$1.8M 1.57%
192,500
+117,500
+157% +$924K
TEVA icon
9
Teva Pharmaceuticals
TEVA
$37.3B
$1.59M 1.39%
+180,000
New +$1.78M
MSFT icon
10
Microsoft
MSFT
$2.93T
$360K 0.31%
1,250
-236
-16% -$60.2K
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.23T
$359K 0.31%
3,465
-288
-8% -$27.6K
VYNE icon
12
VYNE Therapeutics
VYNE
$25.4M
$354K 0.31%
115,000
+27,778
+32% +$99.7K
META icon
13
Meta Platforms (Facebook)
META
$1.64T
$285K 0.25%
1,345
-917
-41% -$156K
TBT icon
14
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$289M
$280K 0.24%
+10,000
New +$293K
V icon
15
Visa
V
$682B
$236K 0.21%
1,045
-309
-23% -$68.8K
AAPL icon
16
Apple
AAPL
$4.9T
$232K 0.2%
1,408
-370
-21% -$54.6K
MA icon
17
Mastercard
MA
$480B
$226K 0.2%
622
-157
-20% -$57K
CRM icon
18
Salesforce
CRM
$140B
$211K 0.18%
+1,054
New +$178K
MSOS icon
19
AdvisorShares Pure US Cannabis ETF
MSOS
$905M
$156K 0.14%
+27,500
New +$182K
DISH
20
CALL
DELISTED
DISH Network Corp.
DISH
$140K 0.12%
+15,000
New +$189K
DISH
21
DELISTED
DISH Network Corp.
DISH
$140K 0.12%
+15,000
New +$189K
QQQ icon
22
Invesco QQQ Trust
QQQ
$466B
$13.2K 0.01%
+41
New +$12.1K
ACN icon
23
Accenture
ACN
$87.9B
– –
-784
Closed -$209K
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.06T
– –
-674
Closed -$208K

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, DSC Advisors held 24 positions worth $115M, up 163% from $43.5M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

DSC Advisors deployed $64.8M of net new capital in Q1 2023, opening 9 new positions and adding to 4 existing holdings. Its largest new stake was Teva Pharmaceuticals: 180,000 shares worth $1.59M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 60% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $156K trimmed.

  • DSC Advisors's largest Q1 2023 buy was Teva Pharmaceuticals: 180,000 shares worth $1.59M.
  • DSC Advisors added most to CVS Health in Q1 2023, an estimated $2.64M increase.
  • DSC Advisors's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $156K.
  • DSC Advisors fully exited Accenture in Q1 2023, selling an estimated $209K.
  • DSC Advisors's ten largest holdings make up 98% of its $115M portfolio in Q1 2023.
  • DSC Advisors opened 9 new positions and closed 2 in Q1 2023.
  • DSC Advisors's portfolio value rose 163% quarter-over-quarter to $115M.

Based on DSC Advisors's 13F filing for Q1 2023, filed 15 May 2023.